Techno Trends
Quanticate partners with CluePoints to offer Data Quality Oversight capabilities
Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints™ to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as...
Techno Trends
Merck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients
HAPPYneuron will be available for inclusion in Merck’s MSdialog platform for use with Rebif® (interferon beta-1a) Agreement provides Merck with exclusive license to cognitive remediation training programs Merck, a leading science and technology company,...
Techno Trends
McKesson Launches NEW Drug Spend Intelligence Tool
McKesson announced the launch of its new Drug Spend Intelligence™ tool. Designed by hospital pharmacists, Drug Spend Intelligence is an easy-to-use online tool that provides the information needed to identify purchase trends, evaluate the impact of price fluctuations, and...
Techno Trends
Novartis Access
The menace of noncommunicable diseases (NCDs) like cardiovascular diseases, diabetes and cancer in the developing world is increasing. These conditions disproportionally affect poverty-stricken areas. Already today 28 million people die each year from these types of diseases in low-...
Techno Trends
Teva’s unique Talent Management program facilitates early detection of employees with high potential
Leadership Development Our vision is to consistently develop individuals and improve overall performance to support Teva in attaining its strategy of business growth. Career development at Teva is therefore considered an essential element and perceived as a...
Techno Trends
Mene Pangalos elected to the Fellowship of the Academy of Medical Sciences
IMED leader one of 48 new fellows recognised for the advancement of medical science in the UK Each year the Academy of Medical Sciences elect a small number of UK scientists to their Fellowship in recognition...
Techno Trends
AstraZeneca and the University of Cambridge announce new joint PhD and clinical research scholarships
AstraZeneca and the University of Cambridge today announced three new joint schemes to support more than 80 PhD scholarships and eight clinical lectureships over the next five years spanning translational science, basic and clinical research. The programmes reflect the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
